APA

Ko J. J., Choueiri T. K., Rini B. I., Lee J., Kroeger N., Srinivas S., Harshman L. C., Knox J. J., Bjarnason G. A., MacKenzie M. J., Wood L., Vaishampayan U. N., Agarwal N., Pal S. K., Tan M., Rha S. Y., Yuasa T., Donskov F., Bamias A. & Heng D. Y. C. (20140605). First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC. : British journal of cancer.

Chicago

Ko J J, Choueiri T K, Rini B I, Lee J-L, Kroeger N, Srinivas S, Harshman L C, Knox J J, Bjarnason G A, MacKenzie M J, Wood L, Vaishampayan U N, Agarwal N, Pal S K, Tan M-H, Rha S Y, Yuasa T, Donskov F, Bamias A and Heng D Y C. 20140605. First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC. : British journal of cancer.

Harvard

Ko J. J., Choueiri T. K., Rini B. I., Lee J., Kroeger N., Srinivas S., Harshman L. C., Knox J. J., Bjarnason G. A., MacKenzie M. J., Wood L., Vaishampayan U. N., Agarwal N., Pal S. K., Tan M., Rha S. Y., Yuasa T., Donskov F., Bamias A. and Heng D. Y. C. (20140605). First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC. : British journal of cancer.

MLA

Ko J J, Choueiri T K, Rini B I, Lee J-L, Kroeger N, Srinivas S, Harshman L C, Knox J J, Bjarnason G A, MacKenzie M J, Wood L, Vaishampayan U N, Agarwal N, Pal S K, Tan M-H, Rha S Y, Yuasa T, Donskov F, Bamias A and Heng D Y C. First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC. : British journal of cancer. 20140605.